| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |